A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/06 (2006.01) A61K 31/137 (2006.01) A61K 31/16 (2006.01) A61K 31/277 (2006.01) A61K 31/4545 (2006.01) A61K 31/47 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2488311
The present invention relates to a method of treating depression or anxiety in a mammal, including a human, by administering to the mammal a CNS-penetrant NK- 1 receptor antagonist (e. g., a substance P receptor antagonist) in combination with an NK-3 antagonist agent. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a CNS-penetrant NK-1 receptor antagonist and an NK-3 antagonist.
La présente invention concerne une méthode de traitement de la dépression ou de l'anxiété chez un mammifère, y compris chez l'homme, par administration audit mammifère d'un antagoniste du récepteur NK-1 agissant sur le SNC (par exemple, un antagoniste du récepteur de la substance P) en combinaison avec un agent antagoniste NK-3. L'invention concerne également des compositions pharmaceutiques contenant un support pharmaceutiquement acceptable, un antagoniste du récepteur NK-1 agissant sur le SNC et un antagoniste NK-3.
Lowe III John Adams
Mclean Stafford
Sobolov-Jaynes Susan Beth
Pfizer Products Inc.
Sim & Mcburney
LandOfFree
Combination treatment for depression and anxiety by nk1 and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination treatment for depression and anxiety by nk1 and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination treatment for depression and anxiety by nk1 and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1764620